IRONWOOD PHARMACEUTICALS, INC. Costs and Expenses
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Costs and Expenses of $33.73 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2026-08-06
- IRONWOOD PHARMACEUTICALS, INC. costs and expenses for the quarter ending 2026-06-30 was $33.73M, a 15.49% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. costs and expenses for the quarter ending 2026-03-31 was $33.93M, a 51.70% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. costs and expenses for the quarter ending 2025-12-31 was $40.90M, a 30.73% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. costs and expenses for the quarter ending 2025-09-30 was $46.58M, a 29.38% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. costs and expenses for fiscal 2025 was $197.65M, a 23.48% decline from fiscal 2024.
- IRONWOOD PHARMACEUTICALS, INC. costs and expenses for fiscal 2024 was $258.29M, a 81.39% decline from fiscal 2023.
- IRONWOOD PHARMACEUTICALS, INC. costs and expenses for fiscal 2023 was $1.39B, a 766.20% increase from fiscal 2022.
- IRONWOOD PHARMACEUTICALS, INC. costs and expenses for fiscal 2022 was $160.26M, a 11.70% decline from fiscal 2021.
| Period end | Costs and Expenses 3 month | Costs and Expenses 3 month as first filed | Costs and Expenses 6 month | Costs and Expenses 6 month as first filed | Costs and Expenses 9 month | Costs and Expenses 9 month as first filed | Costs and Expenses 12 month | Costs and Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $33.73M 10-Q · filed 2026-08-06 | $67.67M 10-Q · filed 2026-08-06 | $108.57M derived: sum of 3 quarters · filed 2026-08-06 | $155.15M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $33.93M 10-Q · filed 2026-05-07 | $74.84M derived: sum of 2 quarters · filed 2026-05-07 | $121.41M derived: sum of 3 quarters · filed 2026-05-07 | $161.33M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $40.90M 10-K · filed 2026-02-26 | $87.48M derived: sum of 2 quarters · filed 2026-02-26 | $127.40M derived: sum of 3 quarters · filed 2026-08-06 | $197.65M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $46.58M 10-K · filed 2026-02-26 | $86.49M derived: sum of 2 quarters · filed 2026-08-06 | $156.75M 10-Q · filed 2025-11-10 | $215.80M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $39.92M 10-Q · filed 2026-08-06 | $110.17M 10-Q · filed 2026-08-06 | $169.22M derived: sum of 3 quarters · filed 2026-08-06 | $235.18M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $70.25M 10-Q · filed 2026-05-07 | $129.31M derived: sum of 2 quarters · filed 2026-05-07 | $195.26M derived: sum of 3 quarters · filed 2026-05-07 | $264.68M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $59.05M 10-K · filed 2026-02-26 | $125.01M derived: sum of 2 quarters · filed 2026-02-26 | $194.43M derived: sum of 3 quarters · filed 2026-02-26 | $258.29M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $65.96M 10-K · filed 2026-02-26 | $135.38M derived: sum of 2 quarters · filed 2026-02-26 | $199.23M 10-Q · filed 2025-11-10 | $279.20M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $69.42M 10-K · filed 2026-02-26 | $133.28M 10-Q · filed 2025-08-11 | $213.24M derived: sum of 3 quarters · filed 2026-02-26 | $286.96M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $63.86M 10-K · filed 2026-02-26 | $143.82M derived: sum of 2 quarters · filed 2026-02-26 | $217.54M derived: sum of 3 quarters · filed 2026-02-26 | $1.41B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $79.96M 10-K · filed 2025-03-31 | $153.68M derived: sum of 2 quarters · filed 2025-03-31 | $1.34B derived: sum of 3 quarters · filed 2025-03-31 | $1.39B 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $73.72M 10-K · filed 2025-03-31 | $1.26B derived: sum of 2 quarters · filed 2025-03-31 | $1.31B 10-Q · filed 2024-11-07 | $1.35B derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2023-06-30 | $1.19B 10-K · filed 2025-03-31 | $1.23B 10-Q · filed 2024-08-08 | $1.27B derived: sum of 3 quarters · filed 2025-03-31 | $1.31B derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2023-03-31 | $43.96M 10-K · filed 2025-03-31 | $82.80M derived: sum of 2 quarters · filed 2025-03-31 | $122.96M derived: sum of 3 quarters · filed 2025-03-31 | $164.54M derived: sum of 4 quarters · filed 2025-03-31 | ||||
| 2022-12-31 | $38.84M 10-K · filed 2024-02-16 | $79.00M derived: sum of 2 quarters · filed 2024-02-16 | $120.58M derived: sum of 3 quarters · filed 2024-02-16 | $160.26M 10-K · filed 2025-03-31 | ||||
| 2022-09-30 | $40.16M 10-K · filed 2024-02-16 | $81.74M derived: sum of 2 quarters · filed 2024-02-16 | $121.42M 10-Q · filed 2023-11-09 | $181.96M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-06-30 | $41.58M 10-K · filed 2024-02-16 | $81.26M 10-Q · filed 2023-08-09 | $141.80M derived: sum of 3 quarters · filed 2024-02-16 | $180.37M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-03-31 | $39.68M 10-K · filed 2024-02-16 | $100.22M derived: sum of 2 quarters · filed 2024-02-16 | $138.80M derived: sum of 3 quarters · filed 2024-02-16 | $177.73M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2021-12-31 | $60.54M 10-K · filed 2023-02-16 | $99.11M derived: sum of 2 quarters · filed 2023-02-16 | $138.05M derived: sum of 3 quarters · filed 2023-02-16 | $181.49M 10-K · filed 2024-02-16 | ||||
| 2021-09-30 | $38.58M 10-K · filed 2023-02-16 | $77.51M derived: sum of 2 quarters · filed 2023-02-16 | $120.96M 10-Q · filed 2021-11-04 | $186.25M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-06-30 | $38.93M 10-K · filed 2023-02-16 | $82.38M 10-Q · filed 2021-08-05 | $147.68M derived: sum of 3 quarters · filed 2023-02-16 | $205.53M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-03-31 | $43.45M 10-K · filed 2023-02-16 | $108.74M derived: sum of 2 quarters · filed 2023-02-16 | $166.59M derived: sum of 3 quarters · filed 2023-02-16 | $223.31M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2020-12-31 | $65.30M 10-K · filed 2022-02-18 | $123.15M derived: sum of 2 quarters · filed 2022-02-18 | $179.87M derived: sum of 3 quarters · filed 2022-02-18 | $246.58M 10-K · filed 2023-02-16 | ||||
| 2020-09-30 | $57.85M 10-K · filed 2022-02-18 | $114.57M derived: sum of 2 quarters · filed 2022-02-18 | $181.29M 10-Q · filed 2021-11-04 | $258.00M derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-06-30 | $56.72M 10-K · filed 2022-02-18 | $123.44M 10-Q · filed 2021-08-05 | $200.14M derived: sum of 3 quarters · filed 2022-02-18 | $265.42M derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-03-31 | $66.72M 10-K · filed 2022-02-18 | $143.43M derived: sum of 2 quarters · filed 2022-02-18 | $208.71M derived: sum of 3 quarters · filed 2022-02-18 | $289.34M derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2019-12-31 | $76.71M 10-K · filed 2021-02-17 | $141.99M derived: sum of 2 quarters · filed 2021-02-17 | $222.63M derived: sum of 3 quarters · filed 2021-02-17 | $308.29M 10-K · filed 2022-02-18 | ||||
| 2019-09-30 | $65.28M 10-K · filed 2021-02-17 | $145.92M derived: sum of 2 quarters · filed 2021-02-17 | $231.58M 10-Q · filed 2020-11-05 | $332.41M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-06-30 | $80.64M 10-K · filed 2021-02-17 | $166.30M 10-Q · filed 2020-08-06 | $267.13M derived: sum of 3 quarters · filed 2021-02-17 | $479.39M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-03-31 | $85.66M 10-K · filed 2021-02-17 | $123.10M 10-Q · filed 2019-05-02 | $186.49M derived: sum of 2 quarters · filed 2021-02-17 | $398.75M derived: sum of 3 quarters · filed 2021-02-17 | $494.53M derived: sum of 4 quarters · filed 2021-02-17 | |||
| 2018-12-31 | $100.83M 10-K · filed 2020-02-13 | $124.70M 10-K · filed 2019-02-25 | $313.09M derived: sum of 2 quarters · filed 2020-02-13 | $408.87M derived: sum of 3 quarters · filed 2020-02-13 | $497.31M 10-K · filed 2021-02-17 | $585.53M 10-K · filed 2019-02-25 | ||
| 2018-09-30 | $212.26M 10-K · filed 2020-02-13 | $234.78M 10-Q · filed 2018-11-06 | $308.04M derived: sum of 2 quarters · filed 2020-02-13 | $396.48M 10-Q · filed 2019-10-31 | $460.83M 10-Q · filed 2018-11-06 | $467.92M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-06-30 | $95.78M 10-K · filed 2020-02-13 | $121.03M 10-Q · filed 2018-08-06 | $184.22M 10-Q · filed 2019-07-30 | $226.05M 10-Q · filed 2018-08-06 | $255.66M derived: sum of 3 quarters · filed 2020-02-13 | $361.92M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-03-31 | $88.44M 10-K · filed 2020-02-13 | $105.02M 10-Q · filed 2018-05-04 | $159.88M derived: sum of 2 quarters · filed 2020-02-13 | $266.14M derived: sum of 3 quarters · filed 2020-02-13 | $372.23M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2017-12-31 | $71.44M 10-K · filed 2019-02-25 | $177.70M derived: sum of 2 quarters · filed 2019-02-25 | $283.79M derived: sum of 3 quarters · filed 2019-02-25 | $313.64M 10-K · filed 2020-02-13 | $375.66M 10-K · filed 2018-02-22 | |||
| 2017-09-30 | $106.26M 10-K · filed 2019-02-25 | $212.35M derived: sum of 2 quarters · filed 2019-02-25 | $304.22M 10-Q · filed 2018-11-06 | $397.98M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | $106.09M 10-K · filed 2019-02-25 | $197.96M 10-Q · filed 2018-08-06 | $291.72M derived: sum of 3 quarters · filed 2019-02-25 | $386.11M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | $91.87M 10-K · filed 2019-02-25 | $185.63M derived: sum of 2 quarters · filed 2019-02-25 | $280.02M derived: sum of 3 quarters · filed 2019-02-25 | $349.69M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | $93.76M 10-K · filed 2018-02-22 | $188.15M derived: sum of 2 quarters · filed 2018-02-22 | $257.82M derived: sum of 3 quarters · filed 2018-02-22 | $325.83M 10-K · filed 2019-02-25 | ||||
| 2016-09-30 | $94.39M 10-K · filed 2018-02-22 | $164.06M derived: sum of 2 quarters · filed 2018-02-22 | $232.07M 10-Q · filed 2017-11-02 | $291.20M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | $69.67M 10-K · filed 2018-02-22 | $137.68M 10-Q · filed 2017-08-03 | $196.81M derived: sum of 3 quarters · filed 2018-02-22 | $262.57M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-03-31 | $68.01M 10-K · filed 2018-02-22 | $127.14M derived: sum of 2 quarters · filed 2018-02-22 | $192.90M derived: sum of 3 quarters · filed 2018-02-22 | $262.65M derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $59.13M 10-K · filed 2017-02-22 | $124.89M derived: sum of 2 quarters · filed 2017-02-22 | $194.64M derived: sum of 3 quarters · filed 2017-02-22 | $251.64M 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | $65.76M 10-K · filed 2017-02-22 | $135.51M derived: sum of 2 quarters · filed 2017-02-22 | $192.51M 10-Q · filed 2016-11-07 | $263.71M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-06-30 | $69.75M 10-K · filed 2017-02-22 | $126.75M 10-Q · filed 2016-08-08 | $197.95M derived: sum of 3 quarters · filed 2017-02-22 | $251.61M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-03-31 | $57.00M 10-K · filed 2017-02-22 | $128.20M derived: sum of 2 quarters · filed 2017-02-22 | $181.85M derived: sum of 3 quarters · filed 2017-02-22 | $243.81M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2014-12-31 | $71.20M 10-K · filed 2016-02-19 | $124.86M derived: sum of 2 quarters · filed 2016-02-19 | $186.81M derived: sum of 3 quarters · filed 2016-02-19 | $245.81M 10-K · filed 2017-02-22 | ||||
| 2014-09-30 | $53.66M 10-K · filed 2016-02-19 | $115.62M derived: sum of 2 quarters · filed 2016-02-19 | $174.61M 10-Q · filed 2015-11-05 | $226.38M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $61.96M 10-K · filed 2016-02-19 | $120.95M 10-Q · filed 2015-08-07 | $172.72M derived: sum of 3 quarters · filed 2016-02-19 | $234.20M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $58.99M 10-K · filed 2016-02-19 | $110.76M derived: sum of 2 quarters · filed 2016-02-19 | $172.24M derived: sum of 3 quarters · filed 2016-02-19 | $241.79M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $51.77M 10-K · filed 2015-02-18 | $113.25M derived: sum of 2 quarters · filed 2015-02-18 | $182.79M derived: sum of 3 quarters · filed 2015-02-18 | $274.88M 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | $61.48M 10-K · filed 2015-02-18 | $131.03M derived: sum of 2 quarters · filed 2015-02-18 | $223.11M 10-Q · filed 2014-11-05 | $293.99M derived: sum of 4 quarters · filed 2015-02-18 | ||||
| 2013-06-30 | $69.54M 10-K · filed 2015-02-18 | $161.63M 10-Q · filed 2014-08-05 | $232.51M derived: sum of 3 quarters · filed 2015-02-18 | $281.32M derived: sum of 4 quarters · filed 2015-02-18 | ||||
| 2013-03-31 | $92.09M 10-K · filed 2015-02-18 | $162.97M derived: sum of 2 quarters · filed 2015-02-18 | $211.77M derived: sum of 3 quarters · filed 2015-02-18 | $267.21M derived: sum of 4 quarters · filed 2015-02-18 | ||||
| 2012-12-31 | $70.88M 10-K · filed 2014-02-07 | $119.69M derived: sum of 2 quarters · filed 2014-02-07 | $175.12M derived: sum of 3 quarters · filed 2014-02-07 | $223.01M 10-K · filed 2015-02-18 | ||||
| 2012-09-30 | $48.80M 10-K · filed 2014-02-07 | $104.24M derived: sum of 2 quarters · filed 2014-02-07 | $152.13M 10-Q · filed 2013-10-28 | $191.31M derived: sum of 4 quarters · filed 2014-02-07 | ||||
| 2012-06-30 | $55.44M 10-K · filed 2014-02-07 | $103.32M 10-Q · filed 2013-08-08 | $142.51M derived: sum of 3 quarters · filed 2014-02-07 | $176.34M derived: sum of 4 quarters · filed 2014-02-07 | ||||
| 2012-03-31 | $47.88M 10-K · filed 2014-02-07 | $87.07M derived: sum of 2 quarters · filed 2014-02-07 | $120.90M derived: sum of 3 quarters · filed 2014-02-07 | $151.12M derived: sum of 4 quarters · filed 2014-02-07 | ||||
| 2011-12-31 | $39.19M 10-K · filed 2013-02-21 | $73.02M derived: sum of 2 quarters · filed 2013-02-21 | $103.23M derived: sum of 3 quarters · filed 2013-02-21 | $132.01M 10-K · filed 2014-02-07 | ||||
| 2011-09-30 | $33.83M 10-K · filed 2013-02-21 | $64.05M derived: sum of 2 quarters · filed 2013-02-21 | $92.83M derived: sum of 3 quarters · filed 2013-02-21 | |||||
| 2011-06-30 | $30.21M 10-K · filed 2013-02-21 | $58.99M derived: sum of 2 quarters · filed 2013-02-21 | ||||||
| 2011-03-31 | $28.78M 10-K · filed 2013-02-21 | |||||||
| 2010-12-31 | $104.62M 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |